← All stocks

Twist Bioscience Corp

TWST Net selling

CIK 0001581280 #1014 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$20.24M

$8.16M on a plan · $9.22M straight out of an exercise

Sold at will

$2.86M

11 of 24 sales

Net

−$20.24M

−$2.86M against sales at will

By person

13 insiders · 24 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Finn Patrick John

President and COO

—

$9.78M (8) scheduled

−$9.78M

210,802

0.3362%

$25.85M

+24.6%

Leproust Emily M.

Chief Executive Officer

—

$7.52M (7) scheduled

−$7.52M

768,427

1.23%

$94.23M

+54.1%

Cho Dennis

See Remarks

—

$2.12M (3) scheduled

−$2.12M

73,651

0.1175%

$9.03M

−23.2%

Green Paula

SVP of Human Resources

—

$300.35K (2)

−$300.35K

117,014

0.1866%

$14.35M

+30.7%

Laponis Adam

Chief Financial Officer

—

$273.26K (1)

−$273.26K

108,633

0.1732%

$13.32M

+43.9%

WERNER ROBERT F.

Chief Accounting Officer

—

$242.44K (3)

−$242.44K

44,399

0.0708%

$5.44M

+14.7%

Chan Nelson

Director

—

33,251

0.0530%

$4.08M

+40.4%

RAGUSA ROBERT P

Director

—

28,983

0.0462%

$3.55M

+49.3%

CRANDELL KEITH

Director

—

27,571

0.0440%

$3.38M

+53.1%

Starovasnik Melissa A.

Director

—

22,222

0.0354%

$2.72M

+29.5%

CHESS ROBERT

Director

—

21,084

0.0336%

$2.59M

−2.6%

JOHANNESSEN JAN

Director

—

17,754

0.0283%

$2.18M

+1.9%

BLAKE KATRYN

Director

—

17,208

0.0274%

$2.11M

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 13

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 6

Sales straight out of an exercise 7

Sales at will 11

Transactions with no price 0

Shares from compensation/vesting 23,355

History held since 1 Nov 2018